A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
The U.S. Department of Health and Human Services (HHS), which manages Medicare, Medicaid and other federal health programs, takes a hard line against free tests, drugs or offerings provided to patients or doctors, actions which may induce them to prescribe or use a particular drug or service, or use of medical equipment.
